Device
Coronary Artery Stenting
Coronary Artery Stenting is a medical device with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
67%
Ph phase_1
1
17%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
4(80.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Other(1)
Detailed Status
Completed5
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (20.0%)
N/A4 (80.0%)
Trials by Status
completed583%
unknown117%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients
NCT02419833
unknownnot_applicable
Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent
NCT03318796
completed
TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)
NCT01242696
completednot_applicable
The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System
NCT00314275
completednot_applicable
The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions
NCT00217269
Clinical Trials (6)
Showing 6 of 6 trials
NCT02419833Not Applicable
Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients
NCT03318796Not Applicable
Tryton Post Approval Study (PAS) for the Tryton Side Branch Stent
NCT01242696
TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System European Post-Approval Surveillance Study (TE-Prove)
NCT00314275Not Applicable
The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System
NCT00217269Not Applicable
The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions
NCT00248079Phase 1
The Medtronic RESOLUTE Clinical Trial
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6